ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,246.68
0.48%
Dow Jones
39,558.11
0.32%
US Dollar vs MXN
16.8482
0.30%
Brent Oil
82.55
-0.79%
Bitcoin
61,572.82
-2.12%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Coya Therapeutics Inc (COYA)

  7. Coya Therapeutics Inc (COYA) Noticias

COYA Coya Therapeutics Inc

8.25
0.17 (2.10%)
Fuera de horario
Última actualización: 15:30:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Coya Therapeutics Inc COYA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.17 2.10% 8.25 15:30:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
8.06 8.06 8.4799 8.25 8.08
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
09/5/202415:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202415:20EDGAR2Form 8-K - Current report
09/5/202415:10BWCoya Therapeutics Provides a Corporate Update and Reports..
08/5/202416:21EDGAR2Form 8-K - Current report
26/4/202407:15BWCoya Therapeutics Presents Updated ALS Biomarker Data at the..
22/4/202407:15BWCoya Therapeutics to Participate in the Mizuho Neuroscience..
18/4/202407:15BWCoya Therapeutics to Participate in the 3rd Annual ALS Drug..
08/4/202407:15BWCoya Therapeutics Scientific Advisory Board Chairman Dr...
19/3/202407:15BWCoya Therapeutics Provides a Corporate Update and Reports..
12/3/202408:00BWCoya Therapeutics to Participate in BTIG Fireside Discussion
12/3/202407:00BWCoya Therapeutics Presents ALS Biomarker Data at Society of..
06/3/202407:15BWCoya Therapeutics Presents Biomarker Data on..
05/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202407:15BWCoya Therapeutics to Present Data on Immune System and..
22/2/202407:15BWCoya Therapeutics to Present Novel Biomarker Survival Data..
21/2/202407:15BWCoya Therapeutics Issues Letter to Stockholders Highlighting..
13/2/202407:15BWCoya Therapeutics Licenses Intellectual Property Rights for..
02/2/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202407:15BWCoya Therapeutics SAB Chairman Dr. Stanley Appel, M.D...
19/1/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202407:15EDGAR2Form 8-K - Current report
18/1/202407:15BWCoya Therapeutics to Participate in Upcoming Chardan Biotech..
16/1/202415:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/1/202407:15BWCoya Therapeutics Announces Pipeline Expansion of COYA 302..
16/1/202403:06PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
16/1/202402:59PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
05/1/202407:00BWCoya Therapeutics Announces Successful Pre-IND and Type C..
04/1/202415:46EDGAR2Form S-3 - Registration statement under Securities Act of..
20/12/202308:46EDGAR2Form D - Notice of Exempt Offering of Securities
20/12/202307:35EDGAR2Form 8-K - Current report
20/12/202307:30BWMr. Wilbur L. Ross, Former United States Secretary of..
13/12/202307:00BWCoya Therapeutics’ CEO Dr. Howard Berman’s Letter to..
12/12/202307:00BWCoya Therapeutics Announces Closing of $26.5 Million Private..
06/12/202306:30EDGAR2Form 8-K - Current report
06/12/202306:05BWCoya Therapeutics Announces $26.5 Million Private Placement
06/12/202306:00BWCoya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter..
08/11/202308:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202308:03EDGAR2Form 8-K - Current report
08/11/202308:00BWCoya Therapeutics, Inc. Provides Business Update and Reports..
27/10/202308:00BWCoya Announces Acceptance of Oral Presentation, “Regulatory..
09/10/202307:00BWCoya Therapeutics (Coya) Announces Completion of Enrollment..
05/10/202308:00BWCoya Therapeutics Presents New Experimental Data Supporting..
03/10/202308:00BWCoya Therapeutics Announces the Presentation of Human..
27/9/202308:00BWCoya Therapeutics to Present at the LD Micro Investor..
22/9/202308:00BWCoya Therapeutics Licenses Exclusive Worldwide rights to..
07/9/202308:15BWCoya Therapeutics Successfully Engineers Regulatory T Cell..
31/8/202307:00BWCoya Therapeutics Announces Publication of Potential Novel..

Su Consulta Reciente

NASDAQ
COYA
Coya Therapeutics
BOV
KIVO11
Fii Kivo Ci
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados